Monsanto Company / GE Healthcare / SUMMARY AND CONCLUSIONS Background Monsanto Company / /
Continent
North America / /
Country
New Zealand / United States / Australia / /
Event
FDA Phase / /
Facility
SDS PAGE The plant / ILSI International Life Sciences Institute / R1 plant / laboratory In / Parental plant / plant of DMO / GHB119 plant / ARfD Acute Reference Dose bar / laboratory As / plant Analyses / /
IndustryTerm
active site / alternate processing / cottonseed oil / food uses / dicamba manufacturing plant / insertion site / domestically-produced food products / food producing / callus-inducing media containing carbenicillin / food/feed / food supply / typical bioinformatics tools / sequence alignment tool / potential oxidation products / alternate processing resulting / Food products / oil / natural oil / chemical and high fibre dietary products / food / food-producing parts / by-products / manner using bioinformatics tools / putative translation product / food applications / crude cottonseed oil / castor oil plant / food production / edible cottonseed oil / human food / catalytic site / food safety / refined oil / food grade quality oil / main food products / pair-wise comparison algorithm / chemical / food industry / frying oil / /
World Health Organization / Food Safety Authority / OECD / Development OGTR office of the Gene Technology Regulator ORF / OECD Organisation for Economic Co-operation / PV-GHHT6997showing / EPA Environmental Protection Agency / United States of America FAO Food and Agriculture Organization of the United Nations FARRP Food Allergy Research / /
Position
Hsp70 leader / /
Product
cefotaxime / MON88701 / /
ProvinceOrState
Texas / Kansas / Louisiana / New Mexico / South Carolina / North Carolina / Georgia / Arkansas / /
Technology
Bioinformatics / pair-wise comparison algorithm / antibodies / cloning / laser / gene expression / DNA sequencing / gel electrophoresis / confirmed using antibodies / /